Biocryst Pharmaceuticals Inc · Other Income/Expenses (Net)

Latest reported-$68.03Mperiod endingJun 30, 2026

BCRX Other Income/Expenses (Net) ($0.00 → -$68.03M)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

BCRX other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	-73,598,000
Dec 31, 2024	-84,411,000
Dec 31, 2023	-122,520,000
Dec 31, 2022	-95,948,000
Dec 31, 2021	-4,089,000
Dec 31, 2020	-8,057,000
Dec 31, 2019	-9,442,000
Dec 31, 2018	-7,032,000
Dec 31, 2017	-8,371,000
Dec 31, 2016	-6,537,000
Dec 31, 2015	-3,575,000
Dec 31, 2014	582,000
Dec 31, 2013	609,000
Dec 31, 2012	-5,193,000
Dec 31, 2011	-7,361,000
Dec 31, 2010	503,535
Dec 31, 2009	285,689
Dec 31, 2008	2,432,492
Dec 31, 2007	3,224,533
Dec 31, 2006	-26,051,788,191
Dec 31, 2005	27,176,833
Dec 31, 2004	647,745
Dec 31, 2003	-12,686,402,668
Dec 31, 2002	18,703,195
Dec 31, 2001	-4,980,990,488
Dec 31, 2000	-11,568,009,986
Dec 31, 1999	1,200,000
Dec 31, 1998	1,300,000
Dec 31, 1997	1,700,000
Dec 31, 1996	0
Dec 31, 1995	700,000
Dec 31, 1994	0